A repeat dose, 28-day safety and bioavailability study of aripiprazole transdermal patches in healthy male volunteers.
Latest Information Update: 04 May 2017
At a glance
- Drugs Aripiprazole (Primary)
- Indications Psychiatric disorders
- Focus Pharmacokinetics; Proof of concept
- 01 May 2017 Status changed from active, no longer recruiting to completed, as reported in an Aequus Pharmaceuticals media release.
- 03 Apr 2017 Results published in an Aequus Pharmaceuticals media release.
- 03 Apr 2017 Status changed from not yet recruiting to active, no longer recruiting, according to an Aequus Pharmaceuticals media release.